Dissertation > Excellent graduate degree dissertation topics show

Establishment of a Model for Screening of Protein Kinase C Inhibitor and the Screening, Evaluation of the Active Compound

Author: LiLi
Tutor: GengMeiYu
School: Ocean University of China
Course: Pharmacognosy
Keywords: Protein kinase C Metastasis Tumor Inhibitor
CLC: R96
Type: Master's thesis
Year: 2009
Downloads: 139
Quote: 0
Read: Download Dissertation


Protein kinase C is a calcium-dependent and phospho-lipid-activated protein kinase first described by Nishizuka and his coworkers. It plays an important role in the intra-cellular signal transduction. The PKC family consists of at least eleven members, divided into four subgroups: classical PKCs, novel PKCs, atypical PKCs, and PKCμ.Protein kinase C (PKC) rocketed to the forefront of the cancer research field in the early 1980s with its identification as the target of the phorbol esters and a lot of succedent researches validate its key role in carcinogenesis and metastasis. Therefore, PKC is the potential molecular target to develop the treatments of cancer. PKCαis ubiquitously expressed in many tissues and has been associated with cell proliferation, cell-cycle regulation and cell invasion and metastasis; There is a large body of evidence linking PKCβⅡto proliferation, invasion and angiogenesis. Whereas PKCδhas been linked with the induction of the pro-tumorigenic sonic hedgehog (SHH) signalling and Wnt signalling. Therefore, PKCα, PKCβⅡand PKCδhave very close relationship with tumor. Currently several specific inhibitors and oligonucleotides inhibiting cPKCs have entered clinical trials, for example, Aprinocarsen, a selective inhibitor of PKCα, Enzastaurin, a selective inhibitor of PKCβ, but many of the PKC inhibitors being discarded at clinical trials. Therefore, the establishment of the screening model for subtype-specific inhibitor targeting PKCα, PKCβⅡor PKCδwill provide the technology platform for the development of anti-cancer drugs targeting PKC.Based on the above research background, this paper aims to establish the molecular level and cell level screening model targeting PKCα, PKCβⅡor PKCδrespectively using fluorescence polarization technology and transfection, proceed the compounds screening and evaluate the tumor cell behavior effect of the active compound. This paper will provide experimental basis for research and development anti-cancer drugs targeting PKC1. Establishment of the molecular level model for protein kinase C inhibitor screening .Established the molecular level model for protein kinase C inhibitor screening using fluorescence polarization technology, verified the screening model with the PKC inhibitor staurosporine and screened the compounds. The results show that we established a stable screening model for protein kinase C inhibitor and obtained an active compound which inhibited PKCβⅡ.2. Establishment of the cell level model for protein kinase C inhibitor screening and evaluated the effect of the active compound on tumor cell behavior.We obtained PKCα, PKCβⅡor PKCδhigh expressing cell line respectively using p-BABE retrovirus vectors. Western-blot and immunofluorescence chemistry analysis showed that there was a great expression of target proteins. We verified the credibility of the cell level model with the PKC activator PMA and the inhibitor staurosporine and analyzed the effect of the active compound on tumor cell behavior.

Related Dissertations

  1. The Regulate and Controlof Slug on P53-MDM2 System,R730.2
  2. Preliminary Study of Phosphorylation Effect on UGT1A3 Metabolism Activity Towards Drugs,R346
  3. Design, Synthesis and Antitumor Activity of thalidomide derivatives,R965
  4. Atovaquone analogues Design, Synthesis and antitumor activity of,R914
  5. Study on the Preparation of the Low Molecular Weight Fuciodan from Sargassum Henslowianum (C.Agardh) and Anti-tumor Activity,TS254.9
  6. Design, Synthesis and Antitumor Activities Study of Quinoxaline-1,4-dioxide Derivatives,R914
  7. The Study on Anti Tumor and Anti-oxidation Activities in Vitro of Extracts from Oxalis Corniculata L,R285
  8. TRAIL in the regulation of tumor invasion CD4 ~ CD25 ~ Treg,R730.2
  9. Effects of Enzymes on Metabolism of Polycyclic Aromatic Hydrocarbons in Plant,X173
  10. Effects of Angiogenic Factor on Follicular Angiogenesis and Development in Immature Mouse,S865.13
  11. Molecular Cloning, Prokaryotic Expression and Characterization of a Novel Trypsin Inhibitor in the Frog, Lepidobatrachus Laevis,Q78
  12. Study on the Transgenic Tobacco Expressing Protein Kinase Like Gene TA50-10 of Wheat and Analysis of Disease Resistance,S572
  13. Study of Melittin on Tumor Inhibition and Part of Mechanism of Human Hepatocellular Carcinoma HepG-2 Xenograft in Nude Mice,R735.7
  14. The Clinic Value of Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Compared with hPET/CT,R445.2
  15. Therapeutical Effects of Diammonium Glycyrrhizinate Lipid Ligand on Nonalcoholic Steatohepatitis and Its Partly Mechanisms of Action,R575.5
  16. The Effect and Mechanism of p38MAPK Inhibitor CBS3830 on Intimal Hyperplasia in Autogenous Vein Grafts of Diabetic Rats,R587.1
  17. Observastion on Histomorphology, Ultrastructure and Expression of TNF-α, IL-1β of Unbalance of Dynamic and Static Forces Cervical Degeneration Disc in Rat Model Abstract,R681.55
  18. The Clinical Value of Detection of Serum TPS, CEA, CYFRA21-1, NSE for Diagnosis in Patients with Lung Cancer,R734.2
  19. Further Studies on the Side Effects of Imatinib in the Treatment of Patients with GIST,R735
  20. Kinase Activities Analysis and Localization of ZmCCaMK Induced by Abscisic Acid in Leaves of Maize Plants,S513
  21. Effects of the Therapeutic Communication System Intervention on the Postoperative Gynecological Malignant Tumor Patients with Depression,R473.73

CLC: > Medicine, health > Pharmacy > Pharmacology
© 2012 www.DissertationTopic.Net  Mobile